|
Do you know a company that specializes in heart valve
technology that does not require rib-cracking surgery? If so, let them know
that device-and-drug makers Johnson & Johnson and Abbott Laboratories are
looking to pursue companies in the transcatheter-valve market. These
technologies allow doctors to replace heart valves without opening a patient's
chest.
Both companies are looking to catch-up to their competitor, Edwards
Lifesciences Corporation who released their own valve that has already shown to
cut death rates in a study of patients too sick to undergo open-heart surgery.
Their valve, Sapien, inserts a valve with a thin-wire that is threaded through
a patient's arteries and reportedly reduces recovery time from months to weeks.
How long will it take before this technology becomes
mainstream?
Source: Bloomberg
| 
Re: Seeking Transcatheter-Valve Technology
